Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Historical Holders from Q1 2018 to Q3 2025

Symbol: CDLX on Nasdaq
Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 53,041,500
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 22,756,684
Holdings value: $55,312,585
% of all portfolios: 0%
Number of holders: 80
Number of buys: 39
Number of sells: -53
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
CAS Investment Partners, LLC	9.8%	-11%	$5,509,951	-$441,820	5,198,067	-7.4%	CAS Investment Partners, LLC	19 Aug 2025
VANGUARD GROUP INC	4.6%		$5,075,509		2,416,909		The Vanguard Group	30 Jun 2025
BlackRock, Inc.	2.1%		$2,307,852		1,098,977		BlackRock, Inc.	30 Jun 2025

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	22,756,684	$55,312,585	-$1,238,659	$2,215,020	$4,055,190	$2.43	80
2025 Q2	24,551,816	$40,388,162	-$6,876,383	$648,126	$483,524	$1.64	87
2025 Q1	28,581,930	$52,019,339	-$5,385,580	$898,065	$512,876	$1.82	104
2024 Q4	30,318,387	$112,466,412	-$2,088,577	$976,472	$1,887,843	$3.71	105
2024 Q3	30,794,820	$98,563,792	-$20,795,950	$2,480,328	$3,931,928	$3.20	114
2024 Q2	33,695,414	$276,632,230	-$28,175,573	$8,278,143	$7,769,123	$8.21	126
2024 Q1	35,620,190	$516,145,492	+$80,060,594	$18,719,631	$10,709,559	$14.49	145
2023 Q4	77,828	$716,796	+$361,318		$184,200	$9.21	3
2023 Q3	28,041,121	$463,140,509	+$17,702,466	$12,030,150	$12,769,350	$16.50	110
2023 Q2	27,412,381	$173,379,386	-$6,527,556	$2,172,824	$605,456	$6.32	107
2023 Q1	28,652,612	$97,279,327	-$6,567,852	$1,180,927	$500,131	$3.40	99
2022 Q4	29,687,135	$171,598,587	-$27,971,318	$3,213,102	$1,696,244	$5.78	116
2022 Q3	31,170,953	$293,009,519	-$32,121,672	$13,497,000	$3,065,000	$9.40	114
2022 Q2	31,595,692	$705,103,664	-$47,893,962	$2,148,000	$2,262,000	$22.31	128
2022 Q1	32,105,855	$1,765,340,508	+$33,440,619	$24,338,000	$6,838,712	$54.98	143
2021 Q4	32,865,847	$2,172,334,765	+$84,370,855	$35,840,000	$10,899,000	$66.09	153
2021 Q3	31,144,181	$2,614,210,687	-$72,878,610	$38,340,552	$16,619,918	$83.94	160
2021 Q2	31,376,638	$3,977,739,304	+$124,455,773	$10,763,000	$14,965,000	$126.93	187
2021 Q1	30,551,628	$3,353,407,688	+$222,326,760	$9,883,000	$8,820,000	$109.70	201
2020 Q4	25,263,261	$3,605,983,154	-$45,231,726	$43,742,000	$30,588,000	$142.77	190
2020 Q3	26,582,576	$1,875,491,237	+$107,136,224	$5,343,000	$11,800,000	$70.57	158
2020 Q2	25,011,926	$1,750,112,005	+$227,704,225	$6,697,000	$14,704,000	$69.98	163
2020 Q1	22,082,673	$772,061,581	-$61,475,781	$3,062,000	$3,602,000	$34.96	138
2019 Q4	23,008,936	$1,446,322,852	+$109,382,419	$2,546,000	$1,299,000	$62.86	154
2019 Q3	21,149,069	$708,918,095	+$86,798,835			$33.52	115
2019 Q2	19,153,490	$497,331,093	+$81,121,882			$25.98	77
2019 Q1	16,277,081	$269,478,973	+$7,217,515			$16.54	61
2018 Q4	16,093,918	$174,294,975	+$5,020,262			$10.83	60
2018 Q3	11,907,497	$296,625,022	+$46,193,877			$25.04	58
2018 Q2	10,049,202	$217,102,831	+$13,927,748			$21.76	51
2018 Q1	9,527,471	$137,886,708	+$137,886,782			$14.63	50